March 14 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Ashland, Oportun Financial and Palomar Holdings on Thursday.
HIGHLIGHTS
* Ashland Inc : Jefferies raises to buy from hold
* Oportun Financial Corp : Jefferies cuts to hold from buy
* Palomar Holdings Inc : Jefferies raises to buy from hold
Following is a summary of research actions on U.S. companies reported by Reuters on Thursday. Stock entries are in alphabetical order.
* Absci Corp : Scotiabank initiates coverage with sector outperform rating
* Absci Corp : Scotiabank initiates coverage with target price $13
* Alexander & Baldwin Inc (Hawaii) : Piper Sandler cuts PT to $17 from $19
* Ashland Inc : Jefferies raises target price to $126 from $100
* Ashland Inc : Jefferies raises to buy from hold
* Avalonbay Communities Inc : Truist Securities cuts target price to $201 from $203
* Dollar Tree Inc : JP Morgan cuts target price to $144 from $165
* Dollar Tree Inc : Piper Sandler cuts target price to $168 from $171
* Iovance Biotherapeutics Inc : Piper Sandler raises target price to $19 from $18
* Jamf Holding Corp : Barclays raises target price to $20 from $18
* Mirum Pharmaceuticals Inc : Leerink Partners raises target price to $44 from $41
* Oportun Financial Corp : Jefferies cuts target price to $3.5 from $9
* Oportun Financial Corp : Jefferies cuts to hold from buy
* Palomar Holdings Inc : Jefferies raises target price to $88 from $78
* Palomar Holdings Inc : Jefferies raises to buy from hold
* Rallybio Corp : Jonestrading cuts target price to $20 from $30
* Tempest Therapeutics : Scotiabank initiates coverage with sector outperform rating
* Tempest Therapeutics : Scotiabank initiates coverage with target price $13
* Williams-Sonoma Inc : JP Morgan raises target price to $245 from $145
* Wingstop Inc : Jefferies raises target price to $310 from $280
(Compiled by Bengaluru Newsroom)
((Diaries@thomsonreuters.com))
Comments